Company: CRNX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000950170-25-066982
Chunk: 13

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 6
Chunk 13
---
EXHIBIT INDEX

     Exhibit
      
     Incorporated by Reference
     Filed

     Number
     Exhibit Description
     Form
     File No.
     Exhibit
     Filing Date
     Herewith

     3.1
     Amended and Restated Certificate of Incorporation
     8-K
     001-38583
     3.3
     7/20/2018

     3.2
     Amended and Restated Bylaws
     8-K
     001-38583
     3.1
     12/12/2023

     4.1
     Specimen Stock Certificate Evidencing the Shares of Common Stock
     S-1/A
     333-225824
     4.1
     7/9/2018

     10.1
     Consulting Agreement, effective as of April 1, 2025, between Crinetics Pharmaceuticals, Inc. and Marc Wilson
     8-K
     001-38583
     10.1
     4/4/2025

     10.2†#
     Employment Agreement, effective as of February 21, 2025, between Crinetics Pharmaceuticals, Inc. and Tobin Schilke

     X

     31.1
     Certification of Chief Executive Officer pursuant to Rule 13(a)-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002

     X

     31.2
     Certification of Chief Financial Officer pursuant to Rule 13(a)-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002

     X

     32.1*
     Certification of Chief Executive Officer and Chief Financial Officer pursuant 18. U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002

     X

     101.INS
     Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document

     X

     101.SCH
     Inline XBRL Taxonomy Extension Schema Document.

     X

     104
     Cover Page Interactive Data File (formatted as inline XB